PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33112540-7	2020	qPCR and western blot revealed that a combination of Sorafenib (10 mumol/L) and cisplatinum (10 mg/L) reduced the transcription and protein expression of autophagy-related AKT and mTOR but increased that of LC3 (P <0.05).	Sorafenib	53-62	AKT serine/threonine kinase 1	Homo sapiens	172-175	
33112540-8	2020	CONCLUSION: Combining Sorafenib and cisplatinum can effectively induce cell autophagy and reduce cellular proliferation via the PI3K/AKT/mTOR signal pathway.<br />.	Sorafenib	22-31	AKT serine/threonine kinase 1	Homo sapiens	133-136